# South Korea Positron Emission Tomography Devices Market

> South Korea Positron Emission Tomography Devices Market Research Report By Application (Oncology, Cardiology, Neurology, Infectious Diseases), By Product Type (Integrated PET-CT Systems, Standalone PET Systems, PET-MRI Systems), By End User (Hospitals, Diagnostic Imaging Centers, Research Institutes) and By Technology (Time-of-Flight PET, Digital PET, Analog PET)Forecast to 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.23%
- **2024:** $ 99 Million
- **2025:** $ 105.17 Million
- **2035:** $ 192.5 Million
- **Key Players:** Siemens Healthineers (DE), GE Healthcare (US), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Medtronic (US), Hitachi Medical Corporation (JP), Nuclear Imaging (US)

**Report ID:** MRFR/MED/52058-HCR · **Pages:** 200 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-korea-positron-emission-tomography-devices-market-53820

---

## Market Summary

## **South Korea Positron Emission Tomography Devices Market Overview**

As per MRFR analysis, the South Korea Positron Emission Tomography Devices Market Size was estimated at 65.25 (USD Million) in 2023. The South Korea Positron Emission Tomography Devices Market is expected to grow from 69.25 (USD Million) in 2024 to 173.12 (USD Million) by 2035. The South Korea Positron Emission Tomography Devices Market CAGR (growth rate) is expected to be around 8.687% during the forecast period (2025 - 2035).

### **Key South Korea Positron Emission Tomography Devices Market Trends Highlighted**

The South Korea Positron Emission Tomography (PET) devices market is witnessing notable developments, shaping its future. One key driver of market growth is the increasing attention given to the early detection and diagnosis of diseases, especially cancer. Considering the high incidence of different cancers in South Korea, there is a growing need for sophisticated imaging technologies such as PET scans.

This is further supported by the government’s efforts to improve the healthcare system and increase access to advanced diagnostic tools for their providers. Another noteworthy trend is the application of artificial intelligence to PET imaging, which enhances the accuracy and speed of diagnosis, thus making the technology even more preferable in clinical practices.

Opportunities abound in this market, including increased investment into researching and developing new radiopharmaceuticals. Numerous universities and research centers in South Korea are working on improving the capabilities of PET devices with innovative imaging PET agents. There is also increased cooperation between healthcare service providers and technology developers.

This cooperation can result in more efficient imaging devices suitable for the region. Recently, there has been a focus on mobile PET imaging units. These units allow greater access to imaging services within remote regions. This is important in a country like South Korea, where urban-rural divides exist when it comes to healthcare access.

Moreover, the shift in the public's attitude towards the value of PET scans is reassuring. This positive perception is likely to encourage early medical checkups. The trends suggest that the South Korean market for healthcare services is responsive to change, mobility, technological innovation, and a shift in the need for radiopathic services.

## **South Korea Positron Emission Tomography Devices Market Drivers**

### **Growing Incidence of Cancer and Chronic Diseases**

The increasing incidence of cancer and chronic diseases is a significant driver for the South Korea Positron Emission Tomography Devices Market Industry. According to the Korean National Cancer Center, there has been a notable uptick in cancer diagnoses, with a 29.6% increase in new cancer cases reported over the last decade. This alarming trend is attributed to factors such as an aging population and lifestyle changes.

Given that Positron Emission Tomography devices are essential for accurate and early diagnosis of cancer, this surge in cancer cases directly boosts demand for such imaging technology. Established organizations, such as Samsung Medical Center, have also been reinforcing advanced imaging techniques to combat the surge in chronic conditions, further supporting the market's expansion potential.

### **Technological Advancements in Imaging Solutions**

Technological advancements play a crucial role in the growth of the South Korea [Positron Emission Tomography Devices Market](../../../reports/positron-emission-tomography-devices-market-7254) Industry. The development of hybrid imaging systems, which combine Positron Emission Tomography with Computed Tomography (CT), has led to enhanced diagnostic precision and patient outcomes. The Ministry of Health and Welfare in South Korea supports these advancements through funding and initiatives.

These initiatives aim at integrating cutting-edge imaging technologies into healthcare facilities. With an estimated increase in operational efficiency by up to 40% for hospitals adopting these advanced systems, market players are incentivized to invest in Research and Development, propelling the growth prospects of the Positron Emission Tomography devices market.

### **Government Initiatives to Enhance Healthcare Infrastructure**

The South Korean government’s initiatives to bolster healthcare infrastructure significantly contribute to the South Korea Positron Emission Tomography Devices Market Industry. The implementation of the 'Healthcare Improvement Plan 2020-2025' aims to enhance nationwide healthcare facilities, including the adoption of advanced diagnostic devices like Positron Emission Tomography. With a projected budget increase of approximately 12% for healthcare spending by 2025, hospitals are poised to invest in state-of-the-art imaging technologies. This governmental support helps to facilitate greater access to advanced diagnostic tools, fostering a conducive environment for market growth.

## **South Korea Positron Emission Tomography Devices Market Segment Insights**

### **Positron Emission Tomography Devices Market Application Insights**

The South Korea Positron Emission Tomography Devices Market is witnessing significant advancements in the Application segment, focusing on its diverse capabilities in the healthcare landscape. Among the key applications, Oncology stands out as a major driver of market demand, attributed to the increasing incidence of cancer and the need for accurate diagnostics and treatment planning.

The ability of Positron Emission Tomography to provide detailed metabolic information about tumors has positioned it as an essential tool in oncological care. Cardiology is another vital application area, where Positron Emission Tomography is gaining traction due to its effectiveness in assessing cardiac viability and perfusion.

As cardiovascular diseases remain a significant health concern in South Korea, advancements in imaging technologies are becoming critical in providing timely and precise treatment options. In addition, Neurology is an emerging segment within the South Korea Positron Emission Tomography Devices Market.

Here, the technology is being utilized to enhance understanding and management of neurological disorders, including Alzheimer’s disease and other dementias. The increasing prevalence of neurodegenerative diseases in an aging population underscores the importance of this application for early diagnosis and prognosis.

Furthermore, the segment covering Infectious Diseases is gaining prominence as healthcare providers seek improved diagnostic tools for conditions such as tuberculosis and other infectious agents, particularly in the wake of heightened global health awareness. This sector’s importance has grown, especially in response to pandemic situations that demand rapid and accurate detection measures.

Altogether, these application areas collectively mark a transformative phase in the South Korea Positron Emission Tomography Devices Market, reflecting an overarching trend towards technological integration in complex diagnostic scenarios. The interplay of technological advancements, patient needs, and healthcare policies in South Korea is anticipated to drive continued investment and innovation in the Positron Emission Tomography realm, ultimately enhancing patient care through improved imaging capabilities.

### **Positron Emission Tomography Devices Market Product Type Insights**

The South Korea Positron Emission Tomography Devices Market exhibits a diverse range of product types, emphasizing the growing demand for advanced imaging technologies in the healthcare sector. Integrated PET-CT Systems have gained immense popularity due to their ability to provide comprehensive diagnostic information through simultaneous imaging.

This enhances the accuracy of disease detection and treatment planning. Standalone PET Systems are noteworthy for their simplicity and effectiveness, offering significant advantages in specific clinical applications, making them a preferred choice in various healthcare facilities. PET-MRI Systems represent a cutting-edge innovation, merging the high-resolution capabilities of MRI with the functional insights of PET.

This enhances diagnostic precision for complex conditions like cancer and neurological disorders. The increasing prevalence of chronic diseases in South Korea is anticipated to drive robust demand across these product segments, as healthcare providers seek state-of-the-art solutions to improve patient outcomes. Furthermore, ongoing advancements in technology and the push for improved diagnostic tools present substantial opportunities for market growth, making it a critical segment in the South Korean healthcare landscape.

### **Positron Emission Tomography Devices Market End User Insights**

The End User segment of the South Korea Positron Emission Tomography Devices Market plays a crucial role in the healthcare landscape, influencing patient diagnostics and treatment planning. Hospitals are among the prominent users, contributing significantly to the demand for advanced imaging technologies as they strive to improve patient outcomes and streamline operational efficiency.

Diagnostic Imaging Centers are also essential, focusing on providing specialized imaging services, catering to a growing need for precise and rapid diagnostics in various medical conditions. Research Institutes utilize Positron Emission Tomography technology extensively in academic and clinical studies, contributing to innovative methodologies for disease management and treatment discovery.

The market dynamics are shaped by the rising incidence of chronic diseases and the increasing emphasis on early diagnostics, driving growth across these segments. South Korea’s government initiatives aimed at enhancing healthcare infrastructure and supporting medical research further fuel the adoption of advanced imaging devices, solidifying the significance of Hospitals, Diagnostic Imaging Centers, and Research Institutes in the overall market ecosystem. Emerging technologies and increasing healthcare expenditure are also expected to elevate the growth potential of this market segment.

### **Positron Emission Tomography Devices Market Technology Insights**

The Technology segment of the South Korea Positron Emission Tomography Devices Market plays a pivotal role in enhancing diagnostic imaging capabilities within the country. Time-of-Flight PET technology stands out for its ability to provide superior image quality by improving the accuracy of detecting gamma photons, leading to better patient outcomes and precise diagnostics.

Digital PET systems are gaining traction, predominantly due to their advanced imaging capabilities, which facilitate faster scans and reduced radiation exposure for patients, aligning with the growing emphasis on patient safety in healthcare practices. Analog PET continues to be significant in the market, especially in maintaining cost-effective imaging solutions for various healthcare settings. Overall, the diverse applications and advancements in these technologies support the increasing demand for enhanced imaging techniques in South Korea, driven by a robust healthcare infrastructure and a focus on innovative medical solutions.

As advancements continue, these technologies are expected to further contribute to the ongoing transformations in medical diagnostics and patient care.

## **South Korea Positron Emission Tomography Devices Market Key Players and Competitive Insights**

The South Korea Positron Emission Tomography Devices Market is characterized by a dynamic landscape marked by technological advancements and growing demand for innovative diagnostic solutions. As healthcare infrastructure continues to evolve and the prevalence of chronic diseases rises, there is an increasing need for advanced imaging technologies.

This market is influenced by various factors, including governmental healthcare policies, rising awareness about early disease detection, and an expanding healthcare expenditure that is shifting towards adopting advanced diagnostic tools. The competition within this market consists of established imaging device manufacturers and emerging players who are focusing on research and development to create devices that offer enhanced accuracy and efficiency. Companies operating in this segment are continually striving to improve their product offerings and maintain a competitive edge through technological innovations.

Siemens Healthineers holds a significant presence within the South Korea Positron Emission Tomography Devices Market, driven by their commitment to innovation and excellence in healthcare technology. The company is recognized for its cutting-edge PET solutions that integrate advanced imaging technologies, leading to higher accuracy in disease diagnosis and monitoring.

Siemens Healthineers capitalizes on its robust research and development capabilities to launch state-of-the-art PET devices that cater to the specific needs of healthcare providers. Their strong distribution network, effective partnerships, and collaborative initiatives with Korean healthcare institutions enhance their presence in the market. The company's emphasis on customized solutions and exceptional customer support further solidifies its competitive position in the South Korean landscape.

Medytox is another notable player within the South Korea Positron Emission Tomography Devices Market, focusing on the development and distribution of innovative medical imaging devices. The company’s key offerings include advanced PET systems designed for both clinical and research applications, ensuring high-quality imaging and rapid results.

Medytox has established a strong market presence in South Korea through strategic collaborations and partnerships with local healthcare entities, which have enhanced its ability to meet the diverse needs of the medical community. With a robust portfolio of products and a commitment to research, Medytox is well-positioned to leverage its capabilities in the competitive landscape.

Recently, the company has pursued mergers and acquisitions to expand its technological footprint and access new markets, consolidating its position in the steadily growing PET segment in South Korea. This proactive approach has enabled Medytox to remain competitive and leverage the increasing demand for advanced imaging solutions in the region.

### **Key Companies in the South Korea Positron Emission Tomography Devices Market Include**

- [Siemens Healthineers](https://www.siemens-healthineers.com/en-in/molecular-imaging/pet-ct)
- Medytox
- Philips Healthcare
- Canon Medical Systems
- Mediartis
- Neusoft Medical Systems
- Shin Jin Medics
- Samsung Medison
- Esaote
- Toshiba Medical Systems
- Hologic
- Fujifilm Holdings
- GE Healthcare
- Hyundai Medical

## **South Korea Positron Emission Tomography Devices Market Developments**

The South Korea Positron Emission Tomography Devices Market is experiencing notable advancements and growth. In October 2023, Siemens Healthineers announced the launch of a new PET/CT system aimed at improving diagnostic capabilities in local healthcare facilities. Additionally, Philips Healthcare has secured contracts with several South Korean hospitals to supply advanced PET imaging solutions, highlighting the demand for innovative diagnostic tools.

In the past two years, significant developments have been recorded, including the establishment of research collaborations between Medytox and local universities to enhance PET imaging technologies in February 2022. Market growth is underscored by major players like GE Healthcare and Fujifilm Holdings strategizing to expand production capabilities to meet rising regional demand.

Moreover, in March 2023, Canon Medical Systems finalized the acquisition of a key competitor, enhancing their portfolio in the PET devices sector. The South Korean government is also investing in healthcare initiatives to promote the adoption of advanced imaging technologies, which positively impacts the PET market. As a result, industry players are increasingly focusing on Research and Development efforts to drive innovation in this evolving market landscape.

## **South Korea Positron Emission Tomography Devices Market Segmentation Insights**

### **Positron Emission Tomography Devices Market Application Outlook**

- Oncology
- Cardiology
- Neurology
- Infectious Diseases

### **Positron Emission Tomography Devices Market Product Type Outlook**

- Integrated PET-CT Systems
- Standalone PET Systems
- PET-MRI Systems

### **Positron Emission Tomography Devices Market End User Outlook**

- Hospitals
- Diagnostic Imaging Centers
- Research Institutes

### **Positron Emission Tomography Devices Market Technology Outlook**

- Time-of-Flight PET
- Digital PET
- Analog PET

## Market Drivers

### Aging Population

The demographic shift towards an aging population in South Korea significantly influences the positron emission-tomography-devices market. By 2025, it is estimated that over 20% of the population will be aged 65 and above, leading to a higher incidence of age-related diseases. This demographic trend necessitates advanced diagnostic tools to effectively manage and treat conditions such as cancer and Alzheimer's disease. The demand for PET devices is likely to surge as healthcare providers seek to enhance diagnostic capabilities and improve patient outcomes. Additionally, the aging population may drive the need for more comprehensive healthcare services, further stimulating the positron emission-tomography-devices market. As the healthcare system adapts to cater to this demographic, investments in advanced imaging technologies will become increasingly critical.

### Increasing Healthcare Expenditure

The rising healthcare expenditure in South Korea is a pivotal driver for the positron emission-tomography-devices market. As the government allocates more funds towards healthcare, the demand for advanced diagnostic tools, including PET devices, is likely to increase. In 2025, healthcare spending is projected to reach approximately $200 billion, reflecting a growth rate of around 5% annually. This financial commitment enables hospitals and clinics to invest in state-of-the-art imaging technologies, enhancing patient care and diagnostic accuracy. Furthermore, the increasing prevalence of diseases such as cancer and neurological disorders necessitates the adoption of advanced imaging techniques, thereby propelling the positron emission-tomography-devices market forward. The focus on improving healthcare infrastructure and technology adoption is expected to create a favorable environment for market growth.

### Rising Awareness of Early Diagnosis

There is a growing awareness among the South Korean population regarding the importance of early diagnosis in disease management, which serves as a significant driver for the positron emission-tomography-devices market. Educational campaigns and healthcare initiatives have emphasized the benefits of early detection, particularly for cancers and other critical conditions. This heightened awareness is likely to lead to increased demand for advanced imaging technologies, including PET devices, as patients and healthcare providers prioritize early diagnostic methods. The market is expected to witness a surge in adoption rates, with projections indicating a potential growth of 10% in the next few years. As more individuals seek preventive healthcare measures, the positron emission-tomography-devices market is poised for substantial expansion.

### Technological Innovations in Imaging

Technological innovations in imaging modalities are transforming the landscape of the positron emission-tomography-devices market. Advancements such as hybrid imaging systems, which combine PET with CT or MRI, are enhancing diagnostic accuracy and efficiency. These innovations are likely to attract healthcare facilities in South Korea to upgrade their imaging capabilities. The introduction of new software algorithms and improved detector technologies is also expected to enhance image quality and reduce scan times. As hospitals and diagnostic centers strive to provide superior patient care, the demand for cutting-edge PET devices is anticipated to rise. The ongoing research and development efforts in imaging technology may further propel the positron emission-tomography-devices market, fostering a competitive environment that encourages continuous improvement.

### Government Initiatives for Healthcare Technology

Government initiatives aimed at promoting healthcare technology adoption are playing a crucial role in shaping the positron emission-tomography-devices market. Policies that encourage investment in advanced medical technologies, including PET devices, are likely to enhance market growth. The South Korean government has implemented various funding programs and incentives to support healthcare facilities in acquiring state-of-the-art imaging equipment. These initiatives are expected to facilitate the integration of advanced diagnostic tools into clinical practice, thereby improving patient outcomes. Furthermore, collaborations between the government and private sector in research and development may lead to innovative solutions in the positron emission-tomography-devices market. As these initiatives gain momentum, the market is poised for significant advancements and expansion.

## Future Outlook

The [Positron Emission Tomography Devices Market](https://www.marketresearchfuture.com/reports/positron-emission-tomography-devices-market-7254) is projected to grow at a 6.23% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare investments.

**New opportunities:**

- Development of AI-integrated imaging systems for enhanced diagnostics.
- Expansion of mobile PET scanning units for remote healthcare access.
- Partnerships with pharmaceutical companies for research and development of radiopharmaceuticals.

By 2035, the market is expected to achieve substantial growth, reflecting advancements and increased adoption.

## Segment Insights

### By Product Type: PET/CT Systems (Largest) vs. PET/MRI Systems (Fastest-Growing)

In the South Korea positron emission-tomography-devices market, the distribution of market share among product types reveals that PET/CT Systems dominate the landscape, holding a significant share due to their widespread adoption in hospitals and diagnostic centers. Conversely, Integrated PET Systems also hold a notable position, providing comprehensive imaging solutions that appeal to various healthcare applications. Despite the strong share of PET/CT Systems, PET/MRI Systems are emerging with a rapidly increasing share, reflecting a shift towards advanced imaging technology.

The growth trends in this segment are driven by an increasing demand for early cancer detection and advancements in imaging technology. PET/MRI Systems, in particular, are gaining traction for their superior imaging capabilities and ability to provide detailed anatomical and functional information simultaneously. The rising prevalence of chronic diseases and age-related health issues further fuels the need for sophisticated diagnostic tools, supporting the growth of all product types within this segment.

PET/CT Systems (Dominant) vs. PET/MRI Systems (Emerging)

PET/CT Systems are currently the dominant product type in the market, favored for their effective combination of metabolic and anatomical imaging, which enhances diagnostic accuracy in various medical scenarios. Their established presence in healthcare facilities contributes to sustained demand. On the other hand, PET/MRI Systems represent an emerging market segment characterized by their advanced imaging techniques that provide exceptional detail and clarity. This emerging technology is particularly appealing due to its lower exposure to ionizing radiation, making it suitable for more sensitive populations. As healthcare providers continuously seek innovative solutions, the rapid advancements and efficiencies of PET/MRI Systems position them well for significant market growth.

### By Application: Oncology (Largest) vs. Cardiology (Fastest-Growing)

In the South Korea positron emission-tomography-devices market, the application for oncology holds the largest share, reflecting its critical role in cancer detection and treatment planning, driving significant demand. Cardiology follows as a significant segment, illustrating the increasing use of PET technology in diagnosing and managing heart diseases, although it constitutes a smaller share in comparison.

The growth trends within the application segment are promising, particularly for cardiology, which is emerging as the fastest-growing sector. This acceleration is primarily driven by advancements in technology and the rising prevalence of cardiovascular diseases. Furthermore, increased funding for medical research and the integration of PET imaging in clinical guidelines are expected to fuel ongoing growth in both oncology and cardiology applications.

Oncology (Dominant) vs. Infectious Diseases (Emerging)

Oncology remains the dominant application within the South Korea positron emission-tomography-devices market, largely attributed to the heightened focus on early detection and personalized treatment approaches for various cancers. The market for infectious diseases is increasingly recognized as emerging, with PET imaging gaining traction for its utility in diagnosing and monitoring diseases such as tuberculosis and various viral infections. This segment, while currently smaller, is expected to grow due to a rising awareness of infectious disease management and technological advancements leading to more effective PET solutions. Both segments showcase the versatility and expanding role of PET in medical diagnostics.

### By End User: Hospitals (Largest) vs. Research Institutes (Fastest-Growing)

In the South Korea positron emission-tomography-devices market, hospitals represent the largest segment, capturing a significant share due to their extensive patient databases and advanced infrastructure. Diagnostic imaging centers follow closely, providing critical support for outpatient diagnostic services. Research institutes, while a smaller segment, are rapidly expanding their presence as advances in research demand more sophisticated imaging technologies.

The growth trends for these segments are driven primarily by technological advancements and an increasing emphasis on early diagnosis and personalized medicine. Hospitals are expanding their capabilities, investing on advanced imaging technologies to enhance diagnostic accuracy. In contrast, research institutes are gaining traction due to heightened funding and initiatives focused on innovative healthcare solutions, making them the fastest-growing segment in the market.

Hospitals (Dominant) vs. Research Institutes (Emerging)

In the South Korea positron emission-tomography-devices market, hospitals are the dominant end user, harnessing large-scale investments in imaging technologies to improve patient outcomes and streamline operations. Their established infrastructure enables efficient integration of advanced positron emission tomography systems, which are critical for a wide range of diagnostic and therapeutic processes. On the other hand, research institutes serve as an emerging segment, leveraging cutting-edge technologies to conduct groundbreaking studies in areas such as oncology and neurology. These institutions are increasingly focusing on innovative applications of positron emission tomography, driven by research grants and collaborations with healthcare providers, highlighting their growing importance in the healthcare landscape.

### By Technology: Time-of-Flight PET (Largest) vs. Digital PET (Fastest-Growing)

In the South Korea positron emission-tomography-devices market, the distribution of market share among segment values reveals Time-of-Flight PET as the largest player due to its advanced imaging capabilities and accuracy. Following closely is Digital PET, which has shown remarkable growth potential. Analog PET, while still relevant, occupies a smaller share, reflecting a gradual shift towards more innovative technologies in the field.

The growth trends within this segment are primarily driven by increasing healthcare investments and technological advancements. Time-of-Flight PET's ongoing enhancements facilitate better diagnosis, while Digital PET is gaining traction due to its efficiency and integration with digital technologies. Moreover, the rising demand for precise imaging in oncology and neurology is propelling these segments forward, emphasizing the need for modern solutions in diagnostic imaging.

Technology: Time-of-Flight PET (Dominant) vs. Digital PET (Emerging)

Time-of-Flight PET stands out as the dominant technology in the South Korea positron emission-tomography-devices market, known for its superior accuracy and speed in imaging processes. This technology enhances diagnostic capabilities by enabling the detection of smaller lesions and improving overall patient outcomes. On the other hand, Digital PET is emerging rapidly, presenting a shift from traditional analog systems. It offers enhanced image quality, faster processing times, and greater integration potential with other digital systems. As the industry moves towards more efficient and effective diagnostic tools, both Time-of-Flight and Digital PETs are positioned to capitalize on these trends, catering to growing demands for precision in medical imaging.

## Competitive Benchmarking

The positron emission-tomography-devices market in South Korea is characterized by a competitive landscape that is increasingly shaped by technological advancements and strategic collaborations. Key growth drivers include the rising prevalence of chronic diseases, an aging population, and the growing demand for early diagnosis and personalized medicine. Major players such as Siemens Healthineers (DE), GE Healthcare (US), and Philips Healthcare (NL) are at the forefront, focusing on innovation and regional expansion. Siemens Healthineers (DE) emphasizes digital transformation and AI integration in its product offerings, while GE Healthcare (US) is enhancing its supply chain capabilities to improve operational efficiency. Philips Healthcare (NL) is pursuing strategic partnerships to bolster its market presence, collectively shaping a dynamic competitive environment.The market structure appears moderately fragmented, with several key players vying for market share. Business tactics such as localizing manufacturing and optimizing supply chains are prevalent among these companies, allowing them to respond swiftly to regional demands. The collective influence of these major players fosters a competitive atmosphere where innovation and operational efficiency are paramount, driving the market forward.

In October  Siemens Healthineers (DE) announced the launch of a new AI-driven PET imaging system designed to enhance diagnostic accuracy and reduce scan times. This strategic move underscores the company's commitment to integrating advanced technologies into its offerings, potentially setting a new standard in the market. The introduction of such innovative solutions may not only improve patient outcomes but also strengthen Siemens' competitive position in the South Korean market.

In September  GE Healthcare (US) revealed a partnership with a leading South Korean hospital network to implement its latest PET technology across multiple facilities. This collaboration aims to enhance diagnostic capabilities and streamline patient care processes. By aligning with local healthcare providers, GE Healthcare (US) is likely to solidify its market presence and gain valuable insights into regional healthcare needs, thereby tailoring its offerings more effectively.

In August  Philips Healthcare (NL) expanded its operations in South Korea by establishing a new research and development center focused on PET technology. This strategic investment reflects Philips' dedication to innovation and its intent to leverage local expertise to drive product development. Such initiatives may enhance Philips' competitive edge by fostering a culture of innovation and responsiveness to market demands.

As of November  the competitive trends in the positron emission-tomography-devices market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, enabling companies to pool resources and expertise to address complex healthcare challenges. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, positioning companies to better meet the demands of a rapidly changing healthcare landscape.

## Recent News & Developments

The South Korea Positron Emission Tomography Devices Market is experiencing notable advancements and growth. In October 2023, Siemens Healthineers announced the launch of a new PET/CT system aimed at improving diagnostic capabilities in local healthcare facilities. Additionally, Philips Healthcare has secured contracts with several South Korean hospitals to supply advanced PET imaging solutions, highlighting the demand for innovative diagnostic tools.

In the past two years, significant developments have been recorded, including the establishment of research collaborations between Medytox and local universities to enhance PET imaging technologies in February 2022. Market growth is underscored by major players like GE Healthcare and Fujifilm Holdings strategizing to expand production capabilities to meet rising regional demand.

Moreover, in March 2023, Canon Medical Systems finalized the acquisition of a key competitor, enhancing their portfolio in the PET devices sector. The South Korean government is also investing in healthcare initiatives to promote the adoption of advanced imaging technologies, which positively impacts the PET market. As a result, industry players are increasingly focusing on Research and Development efforts to drive innovation in this evolving market landscape.

## Report Scope

| MARKET SIZE 2024 | 99.0(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 105.17(USD Million) |
| MARKET SIZE 2035 | 192.5(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.23% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Siemens Healthineers (DE), GE Healthcare (US), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Medtronic (US), Hitachi Medical Corporation (JP), Nuclear Imaging (US) |
| Segments Covered | Product Type, Application, End User, Technology |
| Key Market Opportunities | Advancements in imaging technology enhance diagnostic accuracy in the positron emission-tomography-devices market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive growth in the positron emission-tomography-devices market. |
| Countries Covered | South Korea |

## Frequently Asked Questions

**Q: What is the current valuation of the positron emission-tomography-devices market in South Korea?**
A: The market valuation was $99.0 Million in 2024.

**Q: What is the projected market size for positron emission-tomography-devices in South Korea by 2035?**
A: The projected valuation for 2035 is $192.5 Million.

**Q: What is the expected CAGR for the South Korea positron emission-tomography-devices market during 2025 - 2035?**
A: The expected CAGR during this period is 6.23%.

**Q: Which product type segment is expected to show significant growth in the South Korea market?**
A: The PET/CT Systems segment, valued at $45.0 Million in 2024, is likely to show significant growth.

**Q: What are the key applications driving the positron emission-tomography-devices market in South Korea?**
A: Key applications include Oncology, Cardiology, Neurology, and Infectious Diseases, with Oncology valued at $30.0 Million in 2024.

**Q: Who are the leading players in the South Korea positron emission-tomography-devices market?**
A: Key players include Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems.

**Q: What end-user segments are contributing to the market growth in South Korea?**
A: Hospitals, Diagnostic Imaging Centers, and Research Institutes are the primary end-users, with Hospitals valued at $40.0 Million in 2024.

**Q: What technological advancements are influencing the positron emission-tomography-devices market?**
A: Technologies such as Digital PET and Time-of-Flight PET are influencing the market, with Digital PET valued at $40.0 Million in 2024.

**Q: How does the market for positron emission-tomography-devices in South Korea compare to other regions?**
A: While specific regional comparisons are not provided, the growth trajectory suggests a robust market presence in South Korea.

**Q: What factors are likely to drive the growth of the positron emission-tomography-devices market in South Korea?**
A: Factors include advancements in technology, increasing healthcare expenditure, and a growing focus on early disease detection.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-positron-emission-tomography-devices-market-53820*
